These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 23508615)

  • 41. Cardiovascular risk of carotid atherosclerosis: global consensus beyond societal guidelines.
    Joh JH; Cho S
    Lancet Glob Health; 2020 May; 8(5):e625-e626. PubMed ID: 32353304
    [No Abstract]   [Full Text] [Related]  

  • 42. Epidemiology and clinical outcomes.
    Lüscher TF
    Eur Heart J; 2015 Oct; 36(40):2667-70. PubMed ID: 26489720
    [No Abstract]   [Full Text] [Related]  

  • 43. [Allergic-hyperergic vascular diseases based on several personal observations].
    FISCHER C
    Zentralbl Allg Pathol; 1956 Nov; 95(11):505-9. PubMed ID: 13402096
    [No Abstract]   [Full Text] [Related]  

  • 44. [Hypodermic vascular allergies].
    DUPERRAT B; MONFORT J
    Ann Dermatol Syphiligr (Paris); 1958; 85(4):385-411. PubMed ID: 13571656
    [No Abstract]   [Full Text] [Related]  

  • 45. Nonalcoholic fatty liver disease and cardiovascular diseases: A Mendelian randomization study.
    Peng H; Wang S; Wang M; Ye Y; Xue E; Chen X; Wang X; Fan M; Gao W; Qin X; Wu Y; Chen D; Li J; Hu Y; Wang L; Wu T
    Metabolism; 2022 Aug; 133():155220. PubMed ID: 35618017
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Non-alcoholic fatty liver disease increases risk of carotid atherosclerosis and ischemic stroke: An updated meta-analysis with 135,602 individuals.
    Tang ASP; Chan KE; Quek J; Xiao J; Tay P; Teng M; Lee KS; Lin SY; Myint MZ; Tan B; Sharma VK; Tan DJH; Lim WH; Kaewdech A; Huang D; Chew NW; Siddiqui MS; Sanyal AJ; Muthiah M; Ng CH
    Clin Mol Hepatol; 2022 Jul; 28(3):483-496. PubMed ID: 35232007
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Non-alcoholic fatty liver disease and stroke: A Mendelian randomization study.
    Wu M; Zha M; Lv Q; Xie Y; Yuan K; Zhang X; Liu X
    Eur J Neurol; 2022 May; 29(5):1534-1537. PubMed ID: 35147274
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association of MAFLD With Diabetes, Chronic Kidney Disease, and Cardiovascular Disease: A 4.6-Year Cohort Study in China.
    Liang Y; Chen H; Liu Y; Hou X; Wei L; Bao Y; Yang C; Zong G; Wu J; Jia W
    J Clin Endocrinol Metab; 2022 Jan; 107(1):88-97. PubMed ID: 34508601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Non-alcoholic fatty liver disease and incident major adverse cardiovascular events: results from a nationwide histology cohort.
    Simon TG; Roelstraete B; Hagström H; Sundström J; Ludvigsson JF
    Gut; 2022 Sep; 71(9):1867-1875. PubMed ID: 34489307
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults.
    Alexander M; Loomis AK; van der Lei J; Duarte-Salles T; Prieto-Alhambra D; Ansell D; Pasqua A; Lapi F; Rijnbeek P; Mosseveld M; Avillach P; Egger P; Dhalwani NN; Kendrick S; Celis-Morales C; Waterworth DM; Alazawi W; Sattar N
    BMJ; 2019 Oct; 367():l5367. PubMed ID: 31594780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Non-alcoholic fatty liver disease, liver biomarkers and stroke risk: The Reasons for Geographic and Racial Differences in Stroke cohort.
    Alexander KS; Zakai NA; Lidofsky SD; Callas PW; Judd SE; Tracy RP; Cushman M
    PLoS One; 2018; 13(3):e0194153. PubMed ID: 29529073
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Risk of premature coronary atherosclerosis in patients with nonalcoholic fatty liver disease.
    Taylan G; Ebik M; Solak S; Kaya Ç; Yalta K
    Rev Assoc Med Bras (1992); 2022; 68(10):1428-1433. PubMed ID: 36417648
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pathogenesis of non-alcoholic fatty liver disease and implications on cardiovascular outcomes in liver transplantation.
    Maliakkal BJ
    Transl Gastroenterol Hepatol; 2020; 5():36. PubMed ID: 32632387
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Associations between liver histology and early carotid atherosclerosis in subjects with nonalcoholic fatty liver disease.
    Targher G
    Hepatology; 2005 Oct; 42(4):974-5; discussion 975. PubMed ID: 16175589
    [No Abstract]   [Full Text] [Related]  

  • 55. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients.
    Schindhelm RK; Heine RJ; Diamant M
    Diabetes Care; 2007 Sep; 30(9):e94; author reply e95. PubMed ID: 17726184
    [No Abstract]   [Full Text] [Related]  

  • 56. Fatty liver and the metabolic syndrome.
    Neuschwander-Tetri BA
    Curr Opin Gastroenterol; 2007 Mar; 23(2):193-8. PubMed ID: 17268250
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nonalcoholic fatty liver disease and severity of cardiovascular disease manifestations.
    Athyros VG; Katsiki N; Karagiannis A
    Angiology; 2013 Nov; 64(8):572-5. PubMed ID: 23508615
    [No Abstract]   [Full Text] [Related]  

  • 58. Nonalcoholic fatty liver disease and atherosclerosis.
    Targher G
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):e117; author reply e117-8. PubMed ID: 15980265
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.